Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential

Authors: Stutzman M.J., Kim C.S., Tester D.J., Hamrick S.K., Dotzler S.M., Giudicessi J.R., Miotto M.C., Jeevan B. GC, Frank J,  Marks A.R., Ackerman M.J. 

Stem Cell Reports, 13 September 2022